Neograft Technologies

About Neograft Technologies

Neograft Technologies is a medical device company focused on improving the outcomes of coronary artery bypass grafting (CABG) surgery. The company is developing the Angioshield, a device that creates a supportive, micro-fibrous polymer mesh around a harvested saphenous vein graft.

This external sleeve is applied during the surgical procedure and is designed to improve the vein's durability and performance when used as a bypass conduit. The technology aims to address the common issue of vein graft failure, which can lead to repeat procedures and increased patient risk. The company's primary market is cardiac surgery, serving hospitals and surgical teams that perform heart bypass procedures.